Screener / SEC EDGAR /CIK 0001384101 /10-K filed Feb 26, 2026, compared with Feb 28, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Labs

Veracyte, Inc. VCYT

Compare with peers Embed
Insider trades since May 20, 2026

10 insiders sold $12.5M on the market, none bought

Form 4
Bought on the market $0 0 trades
Sold on the market $12.5M 23 trades by 10 insiders
Sold under a 10b5-1 plan 91% of the value sold, under a plan set up in advance
Traded the most Marc Stapley $6.9M Chief Executive Officer

Open-market buys and sales are the trades an insider chose to make. Grants, option exercises and shares withheld for tax are pay; they show under All.

A year of insider trades, day by day

Open-market buys and sales by officers and directors · Form 4, since Nov 24, 2025

NovDecJanFebMarAprMayJunJulAugSepOctNov Mon Wed Fri

$0 bought on 0 days, $12.5M sold on 11 days. Each square is a day; click one for its Form 4.

SoldBought

Buys and sales by insider

Who traded · Form 4, added up

InsiderBoughtSoldLatest
Marc Stapley
Chief Executive Officer, Director
-$6.9M Jun 4, 2026
Jonathan Wygant
VP, Chief Accounting Officer
-$1.1M May 22, 2026
Karin Eastham
Director
-$940K Oct 27, 2026
Jens Holstein
Director
-$932K Oct 27, 2026
John Leite
Global Chief Commercial Off
-$860K Sep 21, 2026
Phillip G. Febbo
Chief Scientific & Med Officer
-$564K Sep 4, 2026
Robert S. Epstein
Director
-$440K May 20, 2026
Rebecca Chambers
Chief Financial Officer
-$334K Sep 4, 2026
Annie McGuire
EVP, General Counsel
-$298K Sep 4, 2026
Muna Bhanji
Director
-$162K Oct 19, 2026

Owned after: shares held right after the person's latest buy or sale, from the Form 4 the date links to. % of shares: that holding over the shares outstanding on the latest cover page. Only people who bought or sold in this period are listed, and options, restricted units and shares held by others are not counted, so the rows are not a total of what insiders own.

Trade by trade, newest first

Every trade · each date links to its Form 4

Of 23 open-market sales by officers and directors, 3 came in the 30 days before a 10-Q, a 10-K or a results 8-K. Dates only, from the filing index; most companies close the window for insider trades in the weeks before results, so a trade there is often under a 10b5-1 plan.

DateInsiderTypeSharesValue
Oct 27, 2026 Karin Eastham Sale (10b5-1) -14,850 743K
Oct 27, 2026 Jens Holstein Sale (10b5-1) -7,500 375K
Oct 19, 2026 Muna Bhanji Sale (10b5-1) -1,864 81K
Sep 24, 2026 Jens Holstein Sale (10b5-1) -7,500 352K
Sep 21, 2026 John Leite Sale (10b5-1) -4,015 161K
Sep 14, 2026 Jens Holstein Sale (10b5-1) -5,000 205K
Sep 4, 2026 Phillip G. Febbo Sale (10b5-1) -10,405 446K
Sep 4, 2026 Phillip G. Febbo Sale (10b5-1) -2,705 118K
Sep 4, 2026 Rebecca Chambers Sale (10b5-1) -2,477 106K
Sep 4, 2026 Rebecca Chambers Sale (10b5-1) -1,175 51K
Sep 4, 2026 Annie McGuire Sale (10b5-1) -2,154 92K
Sep 4, 2026 Annie McGuire Sale (10b5-1) -1,100 48K
Sep 1, 2026 Muna Bhanji Sale (10b5-1) -1,864 80K
Jun 18, 2026 Karin Eastham Sale (10b5-1) -3,200 169K
Jun 18, 2026 Karin Eastham Sale (10b5-1) -529 28K
Jun 4, 2026 Marc Stapley Sale (10b5-1) -138,051 6.9M
Jun 4, 2026 Rebecca Chambers Sale (10b5-1) -1,600 79K
Jun 4, 2026 Rebecca Chambers Sale (10b5-1) -1,961 98K
Jun 4, 2026 Annie McGuire Sale (10b5-1) -1,400 69K
Jun 4, 2026 Annie McGuire Sale (10b5-1) -1,776 89K
Jun 4, 2026 John Leite Sale (10b5-1) -13,975 700K
May 22, 2026 Jonathan Wygant Sale -24,000 1.1M
May 20, 2026 Robert S. Epstein Sale (10b5-1) -10,000 440K
Show the other 8 trades

Sources

Form 4s from SEC's filing index. An insider files one within two business days of a trade.

Also

Insider selling plans: the 10b5-1 plans and Form 144 notices behind planned sales.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/VCYT/export.csv") into a cell.

Next:Insider selling plans
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.